Pfiz­er makes moves to ac­quire Seagen in po­ten­tial $30B+ deal

Pfiz­er is in talks to ac­quire can­cer drug­mak­er Seagen in a deal that could be worth more than $30 bil­lion, af­ter ac­qui­si­tion talks be­tween Mer­ck …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.